ADMA Biologics Inc (ADMA)
6.735
+0.06
(+0.97%)
USD |
NASDAQ |
May 02, 16:00
6.735
0.00 (0.00%)
After-Hours: 16:06
ADMA Biologics Price: 6.735 for May 2, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
May 01, 2024 | 6.55 | 6.75 | 6.52 | 6.67 | 2.230M |
Apr 30, 2024 | 6.51 | 6.68 | 6.50 | 6.52 | 2.281M |
Apr 29, 2024 | 6.59 | 6.64 | 6.49 | 6.58 | 1.129M |
Apr 26, 2024 | 6.47 | 6.60 | 6.40 | 6.55 | 1.566M |
Apr 25, 2024 | 6.41 | 6.485 | 6.26 | 6.44 | 1.532M |
Apr 24, 2024 | 6.54 | 6.55 | 6.420 | 6.46 | 1.716M |
Apr 23, 2024 | 6.23 | 6.63 | 6.23 | 6.54 | 2.752M |
Apr 22, 2024 | 6.30 | 6.475 | 6.19 | 6.20 | 2.302M |
Apr 19, 2024 | 6.200 | 6.29 | 6.10 | 6.27 | 3.412M |
Apr 18, 2024 | 6.03 | 6.21 | 6.01 | 6.20 | 2.984M |
Apr 17, 2024 | 6.18 | 6.22 | 5.97 | 6.04 | 1.712M |
Apr 16, 2024 | 5.92 | 6.245 | 5.91 | 6.16 | 1.764M |
Apr 15, 2024 | 6.03 | 6.21 | 5.94 | 5.98 | 1.815M |
Apr 12, 2024 | 6.225 | 6.225 | 5.98 | 6.02 | 1.480M |
Apr 11, 2024 | 6.07 | 6.23 | 6.045 | 6.22 | 1.506M |
Apr 10, 2024 | 6.04 | 6.09 | 5.895 | 6.04 | 2.539M |
Apr 09, 2024 | 6.21 | 6.26 | 6.05 | 6.11 | 2.206M |
Apr 08, 2024 | 6.38 | 6.39 | 6.16 | 6.22 | 1.910M |
Apr 05, 2024 | 6.28 | 6.49 | 6.20 | 6.39 | 2.388M |
Apr 04, 2024 | 6.40 | 6.45 | 6.27 | 6.28 | 1.714M |
Apr 03, 2024 | 6.44 | 6.45 | 6.29 | 6.35 | 1.917M |
Apr 02, 2024 | 6.50 | 6.51 | 6.365 | 6.44 | 2.455M |
Apr 01, 2024 | 6.61 | 6.66 | 6.47 | 6.54 | 1.902M |
Mar 28, 2024 | 6.74 | 6.76 | 6.51 | 6.60 | 5.256M |
Mar 27, 2024 | 6.57 | 6.75 | 6.50 | 6.74 | 2.842M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
1.09
Minimum
Oct 11 2021
6.74
Maximum
Mar 27 2024
3.031
Average
2.94
Median
Apr 07 2020
Price Benchmarks
Vanda Pharmaceuticals Inc | 4.68 |
ANI Pharmaceuticals Inc | 67.12 |
Ligand Pharmaceuticals Inc | 72.23 |
Puma Biotechnology Inc | 4.96 |
Bristol-Myers Squibb Co | 43.72 |
Price Related Metrics
PS Ratio | 5.842 |
Price to Book Value | 11.37 |
Price to Free Cash Flow | 394.98 |
Earnings Yield | -1.93% |
Market Cap | 1.537B |
Operating PE Ratio | 69.73 |